Over the last 30 years or so, the support for decision making in drug development projects and portfolios has remained practically the same.
Today, new technologies are available that enables you to evaluate many more options than earlier and also integrate project and portfolio workflows. More evaluated options opens up for both creative thinking and better risk mitigation. When speed of modeling and simulation is not a hinder you will have the time you need to find the best way forward for your project or portfolio. You will be more creative and more pro-active in your work. That may be worth billions.